GLP-1 medications may lower risk of certain cancers

A study suggests GLP-1 medications like Ozempic and Wegovy may lower the risk of certain cancers. Overweight individuals have a higher risk of 13 types of cancer, with 40% of new diagnoses linked to excess weight. GLP-1 treatment reduced the risk of 10 obesity-associated cancers by over half. The study analyzed 1.7 million people with type 2 diabetes. Further research is needed on the relationship between weight loss and cancer risk reduction.